Bando Chemical Industries Ltd. (TYO:5195) announced on April 5 that it signed a share purchase agreement to acquire all shares of Aimedic MMT Co. Ltd., a manufacturer, seller and provider of after-sale services for orthopedic medical devices. Acquired from a fund managed by the Polaris Capital Group Co. Ltd. for around 10.55 billion yen ($94.23 million), Aimedic MMT will become...
Please subscribe to read the full story.Subscribe
Already a member? Log in here
